GLP-1
Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon peptide. It is produced and secreted by intestinal enteroendocrine L-cells and certain neurons within the nucleus of the solitary tract in the brainstem upon food consumption. Wikipedia, CC BY-SA 4.0
- Stories this week
- 9
- Today
- 2
Coverage this week
Separate stories naming GLP-1, by day.
| Day | Stories |
|---|---|
| Thu | 0 |
| Fri | 0 |
| Sat | 0 |
| Sun | 0 |
| Mon | 0 |
| Tue | 7 |
| Today | 2 |
0.1% of News stories in the last 24 hours, about the same as 0.1% over the days before.
Storylines
Today
- Ozempic, Wegovy and other GLP-1 drugs to carry vision loss warning after FDA finds rare eye risk
First: Gizmodo, 2 hr 37 min before anyone else
- Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
First: Townhall, 18 hr 13 min before anyone else
- Popular GLP-1 Weight Loss Drugs Linked to Potential Effects on Brain Health
- GLP-1 Jabs Linked to Scary Side Effect That’s Worse Than ‘Ozempic Face’
Yesterday
- FDA warns of rare 'eye stroke' risk from GLP-1 drugs
- Nation's first gym class for GLP-1 users
- GLP-1 drugs must have new warning label over incurable blindness condition, says FDA
- New research reveals effects of resistance training on people taking GLP-1 drugs
- Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?